Aethlon Medical (AEMD) Moves Down in Pre-Market Trading for June 23

Equities Staff  |

Aethlon Medical Inc (NASDAQ:AEMD) is active in pre-market trading today, June 23, with shares falling 5.88% from the last closing price.

The stock is down 45.16% year-to-date and has moved 0.99% higher over the last 5 days.

For technical charts, analysis, and more on Aethlon Medical visit the company profile.

Pre-market prices and movements as of 07:48:25 est.

About Aethlon Medical Inc

Aethlon is focused on addressing unmet needs in global health. The Aethlon Hemopurifier is a clinical-stage immunotherapeutic device designed to combat cancer and life-threatening viral infections. In cancer, the Hemopurifier is designed to deplete the presence of circulating tumor-derived exosomes that promote immune suppression.

To get more information on Aethlon Medical Inc and to follow the company's latest updates, you can visit the company's profile page here: Aethlon Medical Inc's Profile. For more news on the financial markets be sure to visit Equities News. Also, don't forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Symbol info widget is provided by TradingView based on 15-minute-delayed prices. All other article data is provided by IEX Cloud on 15-minute delayed prices or EOD company info.

Stock price data is provided by IEX Cloud on a 15-minute delayed basis. Chart price data is provided by TradingView on a 15-minute delayed basis.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:

Trending Articles

The Best Laid Plans of Mice and Men — Part II
Why I’m Buying the 'New' Value Stocks
Investors Must Understand 5G Wireless Growth Wave: Jeff Kagan
'Goldilocks' Stocks Will Define This Decade

Market Movers

Sponsored Financial Content